SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-008270
Filing Date
2022-03-31
Accepted
2022-03-31 08:51:46
Documents
14
Period of Report
2022-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40439
2 ex99-1.htm EX-99.1 96519
3 ex99-1_001.jpg GRAPHIC 3176
  Complete submission text file 0001493152-22-008270.txt   332353

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsn-20220331.xsd EX-101.SCH 3030
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsn-20220331_lab.xml EX-101.LAB 34476
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsn-20220331_pre.xml EX-101.PRE 22593
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3617
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 22789317
SIC: 2834 Pharmaceutical Preparations